Clinical Trial Update: Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Ongoing phase 1/2 clinical trial evaluating sintilimab with cetuximab and chemotherapy as first-line therapy for RAS/BRAF wild-type advanced/metastatic colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Chemotherapy (unspecified regimen)
• Sintilimab (Tyvyt) (sintilimab)

Snippet

Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING